New research sheds light on the biomolecular dangers of night shift work.

Vigorous exercise burns fat more in males than in females, but the benefits of exercise are broad for both sexes.

Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

ChatGrid is a practical application of the Department of Energy’s exascale computing efforts and offers a new experience in easy, intuitive, and interactive data interaction.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Results of the PR100 study outline near- and short-term strategies for Puerto Rico to achieve a renewable power grid by 2050.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

Visual Sample Plan, a free software tool developed at PNNL that boosts statistics-based planning, has been recognized with a 2024 Federal Laboratory Consortium Award.

Input from humans helps when deciding whether to trust the recommendations or decisions of a machine-learning system.

PNNL is collaborating with Microsoft, Micron and other partners to make computational chemistry broadly available.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

EGRASS helps prepare and fortify critical structures to protect against the worst consequences of new hurricanes.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

Soil and its microbial inhabitants from Washington state are heading for the International Space Station today.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

A study raises questions about how far droplets, like those that carry the virus that causes COVID-19, can travel before becoming harmless.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.